Page last updated: 2024-09-03

3-iodo-alpha-methyltyrosine and 1-methyl-4-phenylpyridinium

3-iodo-alpha-methyltyrosine has been researched along with 1-methyl-4-phenylpyridinium in 1 studies

Compound Research Comparison

Studies
(3-iodo-alpha-methyltyrosine)
Trials
(3-iodo-alpha-methyltyrosine)
Recent Studies (post-2010)
(3-iodo-alpha-methyltyrosine)
Studies
(1-methyl-4-phenylpyridinium)
Trials
(1-methyl-4-phenylpyridinium)
Recent Studies (post-2010) (1-methyl-4-phenylpyridinium)
83911,8541593

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Leist, M; Lotharius, J; Matt, F; Nagel, DM; Pöltl, D; Salvo-Vargas, A; Schildknecht, S; Schmieg, N; Scholz, D1

Other Studies

1 other study(ies) available for 3-iodo-alpha-methyltyrosine and 1-methyl-4-phenylpyridinium

ArticleYear
Requirement of a dopaminergic neuronal phenotype for toxicity of low concentrations of 1-methyl-4-phenylpyridinium to human cells.
    Toxicology and applied pharmacology, 2009, Nov-15, Volume: 241, Issue:1

    Topics: 1-Methyl-4-phenylpyridinium; Adenosine Triphosphate; Cell Death; Cells, Cultured; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Glutathione; Humans; Lipid Peroxidation; Mesencephalon; Methyltyrosines; Mitochondria; Monoiodotyrosine; MPTP Poisoning; Neurites; Neurons; Time Factors

2009